Treatment of Shoulder Osteoarthritis
Unknown statusNCT05657587
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to learn if pain can be relieved by delivering small amounts of electricity ("electrical stimulation") to the nerves relaying sensory information to the shoulder. This study will use a device called Sprint PNS system. PNS stands for Peripheral Nerve Stimulation. This device is cleared by the FDA for up to 60 days of use for relief of chronic or acute pain.
Study details
- Official title
- A Post Market Observational Case Series Study of Percutaneous Peripheral Nerve Stimulation (PNS) for the Treatment of Chronic Shoulder Pain
- Conditions
- Interventions
- Device: SPRINT PNS
- Sponsor
- Gramercy Pain Center
- Start date
- 2022-04-01
- Primary completion
- 2023-12-31
- Sex
- All
- Age range
- from 21 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Key Inclusion Criteria: * Diagnosed with degenerative changes within the shoulder complex Key Exclusion Criteria: * Pain exclusively in the anterior aspect of the shoulder * Opioids for any condition other than shoulder pain * Other implanted electronic device
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05657587